Rc. Morice et al., Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction, CHEST, 119(3), 2001, pp. 781-787
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Study objective: To evaluate the usefulness of endobronchial argon plasma c
oagulation (APC) for the treatment of hemoptysis and neoplastic airway obst
ruction.
Design: Retrospective study.
Setting: Bronchoscopy unit of a university hospital.
Patients: A total of 60 patients with bronchogenic carcinoma (n = 43), meta
static tumors affecting the bronchi (n = 14), or benign bronchial disease (
n = 3). Indications for intervention were hemoptysis (n = 31), symptomatic
airway obstruction (n = 14), and both obstruction and hemoptysis (n = 25),
Hemoptysis was stratified as a volume of > 200 mL/d (n = 6), > 50 to 200 mL
/d (n = 23), or 150 mL/d but persistence for > 1 week (n = 27). The mean (/- SD) duration of hemoptysis was 16.5 +/- 16.1 days before intervention. O
bstruction sites were the trachea (n = 8), mainstem bronchi (n = 21), and l
obar bronchi (n = 30), In 24 cases, the patient had obstructions at multipl
e sites. The mean size of the pretreatment obstruction was 76 +/- 24.9%,
Interventions: APC, a noncontact form of electrocoagulation, was performed
via flexible bronchoscopy. Sixty patients underwent 70 procedures. Consciou
s sedation without endotracheal intubation was used in all patients except
four, who were mechanically ventilated because of underlying respiratory fa
ilure.
Measurements and results: All patients with hemoptysis experienced a resolu
tion of bleeding immediately after APC. Hemoptysis from treated sires did n
ot recur during a mean follow-up duration of 97 +/- 91.9 days. Patients wit
h endoluminal airway lesions had an overall decrease in mean obstruction si
ze to 18.3 +/- 22.1%. All patients with obstructive lesions, except one who
died of sepsis, experienced symptom improvement. In these patients, sympto
m control was maintained during a median follow-up period of 53 days (range
, 18 to 321 days). There were no complications related to the procedure.
Conclusions: APC is effective for the treatment of endoluminal hemoptysis a
nd airway obstruction, The procedure can be performed in an outpatient sett
ing or at the bedside in the ICUs. APC provides a simpler, lower-risk alter
native to other interventional endobronchial techniques.